Brief: Aptevo Therapeutics - Announces New Solid Tumor Strategy - SEC Filing
27/07/2026 22:11
BRIEF-Aptevo Therapeutics - Announces New Solid Tumor Strategy - SEC Filing July 27 (Reuters) - Aptevo Therapeutics Inc APVO.O:
APTEVO THERAPEUTICS - ANNOUNCES NEW SOLID TUMOR STRATEGY - SEC FILING
APTEVO THERAPEUTICS - FILES PATENT APPLICATION FOR NECTIN-4 X PD-L1 DUAL-TARGETING BACKBONE - SEC FILING
Source text: [ID:n0001193125-26-318056]
Further company coverage: APVO.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary